About Cytochrome P450 3A7
Cytochrome P450 3A7 (CYP3A7) is a protein
from Homo sapiens identified by UniProt accession
P24462, 503 residues long.
MolForge cross-references it against 0 known binders and
132 disease associations.
Target properties
| Protein name | Cytochrome P450 3A7 |
| UniProt accession | P24462 |
| Gene | CYP3A7 |
| Organism | Homo sapiens |
| Length | 503 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (132)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.61
- HIV-1 infection · score 0.60
- COVID-19 · score 0.58
- AIDS · score 0.58
- chronic hepatitis C virus infection · score 0.57
- infection · score 0.55
- hepatitis C virus infection · score 0.55
- HIV-Associated Lipodystrophy Syndrome · score 0.46
- coronavirus infectious disease · score 0.43
- cancer · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P24462-F1 | alphafold | PREDICTED | 92.29 | — |
Amino-acid sequence (503 residues)
MDLIPNLAVE TWLLLAVSLI LLYLYGTRTH GLFKKLGIPG PTPLPFLGNA LSFRKGYWTF DMECYKKYRK VWGIYDCQQP MLAITDPDMI KTVLVKECYS VFTNRRPFGP VGFMKNAISI AEDEEWKRIR SLLSPTFTSG KLKEMVPIIA QYGDVLVRNL RREAETGKPV TLKHVFGAYS MDVITSTSFG VSIDSLNNPQ DPFVENTKKL LRFNPLDPFV LSIKVFPFLT PILEALNITV FPRKVISFLT KSVKQIKEGR LKETQKHRVD FLQLMIDSQN SKDSETHKAL SDLELMAQSI IFIFAGYETT SSVLSFIIYE LATHPDVQQK VQKEIDTVLP NKAPPTYDTV LQLEYLDMVV NETLRLFPVA MRLERVCKKD VEINGMFIPK GVVVMIPSYV LHHDPKYWTE PEKFLPERFS KKNKDNIDPY IYTPFGSGPR NCIGMRFALV NMKLALVRVL QNFSFKPCKE TQIPLKLRFG GLLLTEKPIV LKAESRDETV SGA
Explore Cytochrome P450 3A7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets